- This event has passed.
Waiting for Low Tide: Revelations from the Forefront of Genomic Medicine
May 4, 2018 @ 7:00 pm - 9:00 pm
Nadia Rosenthal hopes someday genomic medicine can fix a broken heart – the kind with cardiac disease. Rosenthal, a molecular biologist who oversees The Jackson Laboratory in Bar Harbor, Maine, will discuss “Waiting for Low Tide: Revelations from the Forefront of Genomic Medicine” on Friday, May 4, in Hamilton. Her presentation begins at 7 p.m. in the Performing Arts Center, 327 Fairgrounds Road. The event is free and intended for a general audience.
Her presentation is part of the Rocky Mountain Laboratories (RML) community outreach series. The Hamilton-based infectious disease research facility is part of the National Institute of Allergy and Infectious Diseases of the U.S. National Institutes of Health.
“As scientists, we have learned how to look below the surface of inquiry, waiting for the moment when we can see clearly what is revealed by the receding ‘tides,’ ” Rosenthal says. “Biomedical research has become a booming area of science, as principles uncovered by recent technological advances in human genetics are being applied to improve health care and treat disease.”
She will help the Hamilton audience consider some of those implications. “Are we ready?” Rosenthal asks, referring to some of the new information and opportunities facing researchers. “Expanding our capacity to interpret and apply these new revelations will have major implications for just about every aspect of medicine and will affect broader aspects of our lives.”
Rosenthal earned her doctorate in biochemistry from Harvard Medical School in 1981. Among her career stops, she spent 12 years at the European Molecular Biology Laboratory in Rome and nine years as founding director of the Australian Regenerative Medicine Institute in Melbourne. She holds a Chair in Cardiovascular Science at Imperial College London and has been scientific director of The Jackson Laboratory since 2015.
Her research focuses on mammalian molecular genetics, the biology of aging, and regenerative medicine – especially involving skeletal muscle and heart disease. Some of her group’s recent projects have explored regeneration in salamanders, and – using mice – how the immune system can improve tissue repair, including in the heart.
“Advances in genetics and our understanding of the human genome have the potential to greatly improve human health and to treat degenerative conditions usually considered incurable,” said Marshall Bloom, M.D., who oversees research at RML. “Dr. Rosenthal is at the forefront of this work and we are truly fortunate to have her visit our community.”
NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website.
About the National Institutes of Health (NIH): NIH, the nation’s medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.